Skip to main content
. 2019 Aug 30;18(5):3525–3533. doi: 10.3892/etm.2019.7962

Figure 3.

Figure 3.

miR-205-5p negatively regulates ERp29 in breast cancer cells. (A) miR-205-5p inhibitor significantly inhibited miR-205-5p expression in the MDA-MB-231 cell line. (B) RT-qPCR results indicated that miR-205-5p inhibitor enhanced ERp29 mRNA expression levels in the MDA-MB-231 cell line. Protein expression levels of ERp29 were determined using (C) western blotting and (D) quantified. (E) RT-qPCR results indicated that miR-205-5p mimic decreased ERp29 mRNA expression levels. Protein expression levels of ERp29 in the MDA-MB-231 cell line were determined using (F) western blotting and (G) analyzed quantitatively. **P<0.01 and ***P<0.001 vs. the respective control group. RT-qPCR, reverse transcription-quantitative PCR; NC, negative control; miR, microRNA; ERp29, endoplasmic reticulum protein 29.